4.4 Review

Is radiotherapy helpful for the prognosis of upper urinary tract urothelial carcinoma? A meta-analysis

Related references

Note: Only part of the references are listed.
Article Oncology

Cancer statistics, 2022

Rebecca L. Siegel et al.

Summary: Each year, the American Cancer Society compiles data on cancer occurrence and outcomes in the United States. The latest data shows that breast and prostate cancer progress has stagnated, while lung cancer has shown improvements in survival rates. Lung cancer incidence for advanced disease has declined while localized-stage rates have increased, resulting in higher survival rates. Mortality patterns align with incidence trends, with lung cancer deaths declining rapidly, breast cancer deaths slowing, and prostate cancer deaths stabilizing.

CA-A CANCER JOURNAL FOR CLINICIANS (2022)

Review Urology & Nephrology

European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update

Morgan Roupret et al.

Summary: The updated EAU guidelines on UTUC aim to assist clinicians in evidence-based management, providing recommendations on diagnosis, risk stratification, radical and conservative treatment, and prognostic factors. Due to the rarity of UTUC, there is insufficient data to provide strong recommendations. Recommendations are based on the 2017 TNM classification and emphasize individualized treatment based on proposed risk stratification.

EUROPEAN UROLOGY (2021)

Article Oncology

The role of surgery on primary site in metastatic upper urinary tract urothelial carcinoma and a nomogram for predicting the survival of patients with metastatic upper urinary tract urothelial carcinoma

Xiaodi Zhang et al.

Summary: Our study established a nomogram to predict the survival of patients with metastatic upper urinary tract urothelial carcinoma, highlighting the importance of surgery at the primary tumor site. Propensity score matching revealed T stage, N stage, hepatic metastasis, surgery, and chemotherapy as prognostic factors for mUTUC. Subgroup analysis indicated that a combination of surgery and chemotherapy could improve survival for certain patient subgroups based on T stage, N stage, and different metastatic sites.

CANCER MEDICINE (2021)

Article Medicine, General & Internal

Competing-risks nomogram for predicting cancer-specific death in upper tract urothelial carcinoma: a population-based analysis

Chengzhuo Li et al.

Summary: The competing-risks model identified sex, tumor size, distant metastasis, surgery status, LNP, and LNR as independent prognostic factors for CSD in UTUC patients. The nomogram predicts the probability of CSD at 3, 5, and 8 years, aiding clinicians in predicting individual patient survival probabilities.

BMJ OPEN (2021)

Article Oncology

Adjuvant Treatments for Advanced Stage, Non-metastatic Upper Tract Urothelial Carcinoma: A Multicenter Study

Myong Kim et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)

Review Oncology

The role of adjuvant radiotherapy after surgery for upper and lower urinary tract urothelial carcinoma: A systematic review

Takehiro Iwata et al.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2019)

Article Urology & Nephrology

Regional differences in practice patterns and associated outcomes for upper tract urothelial carcinoma in Canada

Michael Melcalfe et al.

CUAJ-Canadian Urological Association Journal (2016)

Article Multidisciplinary Sciences

Adjuvant radiotherapy for locally advanced upper tract urothelial carcinoma

Yun-Ching Huang et al.

SCIENTIFIC REPORTS (2016)

Review Urology & Nephrology

Urothelial Carcinoma of the Bladder and the Upper Tract: Disparate Twins

David A. Green et al.

JOURNAL OF UROLOGY (2013)

Article Medicine, Research & Experimental

Practical methods for incorporating summary time-to-event data into meta-analysis

Jayne F. Tierney et al.

TRIALS (2007)